Unipharma Co (ROCO:6621) FFO


ROCO:6621 Unipharma Co Ltd ROCO:6621
74 GF Score
Price NT$11.25
GF Value NT$11.63
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Unipharma Co FFO?

FFO (Funds from operations) only applies to REITs.

ROCO:6621
74GF Score
Unipharma Co Ltd ROCO:6621
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Unipharma Co (ROCO:6621) Overvalued in 2026?

Based on GuruFocus' analysis, Unipharma Co stock appears to be undervalued. The current stock price of NT$11.25 is trading 3.3% below its estimated GF Value™ of NT$11.63. GuruFocus considers Unipharma Co to be Fairly Valued.

Key valuation signals for ROCO:6621:

  • FFO:
  • GF Value™: NT$11.63 vs. price of NT$11.25 (3.3% below fair value)
  • GF Score™: 74/100 with 2 warning signs

No single metric tells the full story. See the ROCO:6621 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Unipharma Co Business Description

Address Jiu Zong Road, 3rd Floor, No. 17, Lane 171, Section 2, NeiHu District, Taipei, TWN, 11494
Unipharma Co Ltd is a medical diagnostic, pharmaceutical and medical device company. It is engaged in developing drug products and medical equipment. The company's products offerings include Baxter, Tambocor tablets, Bain Injection, Esmolol HCL Injection, Naloxone Injection, and SAM Pelvic Sling medical device. Its customers are major medical centers, regional hospitals, regional hospitals, and clinics.
74GF Score

Get the complete analysis for ROCO:6621

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$11.25
Price
NT$11.63
GF Value